A team led by Rutgers has created better biosensor technology that can help lead to safe stem cell therapy for treating Alzheimer's disease and Parkinson's and other diseases in the neurological.
The technology, which features a unique graphene and gold-based platform and high-tech imaging, monitors the fate of stem cells by removing the genetic material (RNA) involved in making such cells in brain cells (neurons), according to a study in the journal Nano Letters .
Stem cells can be many different types of cells. As a result, stem cell therapy demonstrates promise for regenerative treatment of neurological diseases such as Alzheimer's, Parkinson's, stroke and spinal cord injury, with diseased cells requiring replacement or repair. But identifying stem cells and controlling their fate must be resolved before they can be used in treatment. The formation of tumors and uncontrolled transformation of stem cells remain major obstacles.
"A critical challenge is ensuring high sensitivity and accuracy in the removal of biomarkers ̵
The team's unique biosensing platform consists of a set of ultrathin graphene layers and gold nanostructures. The platform, combined with high-tech imaging (Raman spectroscopy), detects genes and identifies different types of stem cells with greater reliability, sequence and sensitivity than the biosensors today.
The team believes that technology can benefit a range of applications. By developing simple, fast and accurate sensing platforms, Lee's group aims to facilitate the treatment of neurological disorders through stem cell therapy.
Stem cells can be a renewable source of replacement cells and tissues to treat diseases including macular degeneration, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis and rheumatoid arthritis, according to at the National Institutes of Health.
New nanotechnology may aid in cell-cell transplantation research
Letao Yang et al, Dual-Enhanced Raman Scattering-Based Characterization of Stem Cell Comparison Using Graphene-Plasmonic Hybrid Nanoarray, Nano Letter (2019). DOI: 10.1021 / acs.nanolett.9b03402
Better biosensor technology created for stem cells (2019, November 11)
acquired on November 11, 2019
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, it is not
the part may be reproduced without written permission. The content is provided for informational purposes only.